Diaphragmatic Surgery During Primary Cytoreduction for Advanced Ovarian Cancer: Peritoneal Stripping Versus Diaphragmatic Resection
- 1 November 2011
- journal article
- research article
- Published by BMJ in International Journal of Gynecologic Cancer
- Vol. 21 (9), 1698-1703
- https://doi.org/10.1097/igc.0b013e31822f65c3
Abstract
Standard approach for medically stable advanced ovarian cancer patients should be primary cytoreduction following platinum-based chemotherapy. The aim of surgical effort should be the complete removal of all visible disease. Our objective was to compare perioperative features, postoperative complications, and secondarily oncological outcomes of patients who underwent diaphragmatic stripping with those who underwent diaphragmatic resection for advanced ovarian cancer. One hundred twelve cases were identified, among them 79 underwent diaphragmatic stripping and 33 underwent diaphragmatic full-thickness resection. Data collected included patients’ age, all perioperative details and pathological findings, International Federation of Gynecology and Obstetrics stage, adjuvant therapy, and follow-up data. Larger residual tumors (mean, 5.1 vs 1.6 mm, respectively;P< 0.01) but shorter operating time (25 minutes shorter operative time,P= 0.07) were observed in the stripping group. Higher postoperative pleural effusions rates (63.6% vs 37.9%,P= 0.01), but no differences in the remaining complications, were observed in the resection group. After a mean of 31 months of follow-up, disease-free survival rates were 27.8% in the stripping group and 39.4% in the resection group (P= 0.04). No significant differences were observed for overall survival. Diaphragmatic surgery at the time of primary cytoreductive surgery for advanced ovarian cancer may contribute to the achievement of complete cytoreduction with low perioperative complication rate; full-thickness resection is preferable if peritoneum stripping will not achieve a complete removal of the disease.Keywords
This publication has 19 references indexed in Scilit:
- Morbidity of diaphragmatic surgery for advanced ovarian cancer: Retrospective study of 148 casesEuropean Journal of Surgical Oncology, 2011
- Upper abdominal surgery in advanced and recurrent ovarian cancer: Role of diaphragmatic surgeryGynecologic Oncology, 2010
- First-line treatment of advanced ovarian cancer: current research and perspectivesExpert Review of Anticancer Therapy, 2010
- Maximal cytoreductive effort in epithelial ovarian cancer surgeryJournal of Gynecologic Oncology, 2010
- Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasiaInternational Journal of Gynecology & Obstetrics, 2009
- Role of Surgery in Ovarian CarcinomaJournal of Clinical Oncology, 2007
- Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancerGynecologic Oncology, 2006
- Does Aggressive Surgery Only Benefit Patients With Less Advanced Ovarian Cancer? Results From an International Comparison Within the SCOTROC-1 TrialJournal of Clinical Oncology, 2005
- Complete Surgical Cytoreduction of Advanced Ovarian Carcinoma Using the Argon Beam CoagulatorGynecologic Oncology, 2001
- Extensive Primary Cytoreductive Surgery for Advanced Epithelial Ovarian CancerGynecologic Oncology, 1994